{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:49:14Z","timestamp":1787968154136,"version":"build-2784847793"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1 R01 AG047992-01A1"],"award-info":[{"award-number":["1 R01 AG047992-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32-AG058524"],"award-info":[{"award-number":["T32-AG058524"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K24 MH110598"],"award-info":[{"award-number":["K24 MH110598"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11764-019-00786-6","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T05:53:04Z","timestamp":1563861184000},"page":"673-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-822X","authenticated-orcid":false,"given":"Jennifer N.","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Newhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"786_CR1","doi-asserted-by":"crossref","unstructured":"Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011 [cited 2014 Jan 22];38:431\u20138. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0093775411000844 .","DOI":"10.1053\/j.seminoncol.2011.03.014"},{"key":"786_CR2","doi-asserted-by":"crossref","unstructured":"Silberfarb PM. Chemotherapy and cognitive defects in cancer patients. Annu Rev Med. 1983 [cited 2014 Feb 26];34:35\u201346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6344764 .","DOI":"10.1146\/annurev.me.34.020183.000343"},{"key":"786_CR3","doi-asserted-by":"crossref","unstructured":"Ahles TA. Brain vulnerability to chemotherapy toxicities. Psychooncology. 2012 [cited 2014 Feb 24];21:1141\u20138. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3788849&tool=pmcentrez&rendertype=abstract .","DOI":"10.1002\/pon.3196"},{"key":"786_CR4","doi-asserted-by":"crossref","unstructured":"Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002 [cited 2014 Feb 18];20:485\u201393. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11786578 .","DOI":"10.1200\/JCO.2002.20.2.485"},{"key":"786_CR5","doi-asserted-by":"crossref","unstructured":"Craig CD, Monk BJ, Farley JH, Chase DM. Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment. Support Care Cancer. 2014 [cited 2014 Apr 4];22:279\u201387. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24212261 .","DOI":"10.1007\/s00520-013-2029-7"},{"key":"786_CR6","doi-asserted-by":"crossref","unstructured":"Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013 [cited 2015 Jun 17];40:709\u201325. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3880205&tool=pmcentrez&rendertype=abstract","DOI":"10.1053\/j.seminoncol.2013.09.006"},{"key":"786_CR7","doi-asserted-by":"crossref","unstructured":"Vega JN, Newhouse PA. Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Curr Psychiatry Rep. 2014 [cited 2014 Aug 30];16:490. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25160795 .","DOI":"10.1007\/s11920-014-0490-8"},{"key":"786_CR8","doi-asserted-by":"crossref","unstructured":"Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015 [cited 2016 Jun 3];65:123\u201338. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4355212&tool=pmcentrez&rendertype=abstract .","DOI":"10.3322\/caac.21258"},{"key":"786_CR9","doi-asserted-by":"crossref","unstructured":"Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012 [cited 2014 Feb 21];12:267\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22453825 .","DOI":"10.1007\/s11910-012-0264-9"},{"key":"786_CR10","doi-asserted-by":"crossref","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016 [cited 2016 Jun 7]; Available from: http:\/\/doi.wiley.com\/10.3322\/caac.21349","DOI":"10.3322\/caac.21349"},{"key":"786_CR11","doi-asserted-by":"crossref","unstructured":"Pedersen AD, Rossen P, Mehlsen MY, Pedersen CG, Zachariae R, von der Maase H. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc. 2009 [cited 2016 May 5];15:296\u2013301. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19203434 .","DOI":"10.1017\/S1355617709090316"},{"key":"786_CR12","doi-asserted-by":"crossref","unstructured":"Wefel JS, Vidrine DJ, Marani SK, Swartz RJ, Veramonti TL, Meyers CA, et al. A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psychooncology. 2014 [cited 2016 Jun 3];23:626\u201333. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4066616&tool=pmcentrez&rendertype=abstract","DOI":"10.1002\/pon.3453"},{"key":"786_CR13","doi-asserted-by":"crossref","unstructured":"Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013 [cited 2016 Jun 3];119:4188\u201395. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3834212&tool=pmcentrez&rendertype=abstract .","DOI":"10.1002\/cncr.28323"},{"key":"786_CR14","doi-asserted-by":"crossref","unstructured":"Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol.2007 [cited 2014 Mar 7];63:183\u2013202. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17678745 .","DOI":"10.1016\/j.critrevonc.2007.06.001"},{"key":"786_CR15","doi-asserted-by":"crossref","unstructured":"Correa DD, Zhou Q, Thaler HT, Maziarz M, Hurley K, Hensley ML. Cognitive functions in long-term survivors of ovarian cancer. Gynecol Oncol. 2010 [cited 2014 Mar 10];119:366\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20630576 .","DOI":"10.1016\/j.ygyno.2010.06.023"},{"key":"786_CR16","doi-asserted-by":"crossref","unstructured":"Chao HH, Uchio E, Zhang S, Hu S, Bednarski SR, Luo X, et al. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis. BMC Cancer. 2012 [cited 2016 Jun 3];12:371. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3502584&tool=pmcentrez&rendertype=abstract .","DOI":"10.1186\/1471-2407-12-371"},{"key":"786_CR17","doi-asserted-by":"crossref","unstructured":"Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002 [cited 2014 Feb 27];3 Suppl 3:S84\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12533268 .","DOI":"10.3816\/CBC.2002.s.018"},{"key":"786_CR18","doi-asserted-by":"crossref","unstructured":"Scheibel RS, Valentine AD, O\u2019Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci. 2004 [cited 2019 Jun 7];16:185\u201391. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15260370 .","DOI":"10.1176\/jnp.16.2.185"},{"key":"786_CR19","doi-asserted-by":"crossref","unstructured":"Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013 [cited 2014 Feb 27];39:297\u2013304. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23219452 .","DOI":"10.1016\/j.ctrv.2012.11.001"},{"key":"786_CR20","doi-asserted-by":"crossref","unstructured":"Vega JN, Dumas J, Newhouse P. Cognitive effects of chemotherapy and cancer-related treatments in older adults. Am J Geriatr Psychiatry. 2017 [cited 2017 Apr 13];25:1415\u201326. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1064748117302786 .","DOI":"10.1016\/j.jagp.2017.04.001"},{"key":"786_CR21","doi-asserted-by":"crossref","unstructured":"Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage. 2009 [cited 2014 Mar 10];38:650\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19896571 .","DOI":"10.1016\/j.jpainsymman.2009.03.011"},{"key":"786_CR22","doi-asserted-by":"crossref","unstructured":"Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer. 2008 [cited 2014 Mar 10];16:577\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17972110 .","DOI":"10.1007\/s00520-007-0341-9"},{"key":"786_CR23","doi-asserted-by":"crossref","unstructured":"Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009 [cited 2014 Mar 10];115:2605\u201316. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2796482&tool=pmcentrez&rendertype=abstract .","DOI":"10.1002\/cncr.24287"},{"key":"786_CR24","doi-asserted-by":"crossref","unstructured":"Lundorff LE, J\u00f8nsson BH, Sj\u00f8gren P. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat Med. 2009 [cited 2014 Mar 10];23:731\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19648224 .","DOI":"10.1177\/0269216309106872"},{"key":"786_CR25","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy JA. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clin Breast Cancer. 2002 [cited 2014 Mar 10];3 Suppl 3:S116\u201320. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12533272 .","DOI":"10.3816\/CBC.2002.s.022"},{"key":"786_CR26","doi-asserted-by":"crossref","unstructured":"Fan HGM, Park A, Xu W, Yi Q-L, Braganza S, Chang J, et al. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psychooncology. 2009 [cited 2014 Feb 16];18:156\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18561284 .","DOI":"10.1002\/pon.1372"},{"key":"786_CR27","doi-asserted-by":"crossref","unstructured":"Shaw EG, Rosdhal R, D\u2019Agostino RB, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006 [cited 2016 Dec 5];24:1415\u201320. Available from: http:\/\/www.jco.org\/cgi\/doi\/10.1200\/JCO.2005.03.3001","DOI":"10.1200\/JCO.2005.03.3001"},{"key":"786_CR28","doi-asserted-by":"crossref","unstructured":"Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, et al. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012 [cited 2016 Dec 5];59:540\u20137. Available from: http:\/\/doi.wiley.com\/10.1002\/pbc.24078","DOI":"10.1002\/pbc.24078"},{"key":"786_CR29","doi-asserted-by":"crossref","unstructured":"Lawrence JA, Griffin L, Balcueva EP, Groteluschen DL, Samuel TA, Lesser GJ, et al. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv [Internet]. 2016 [cited 2016 Jul 20];10:176\u201384. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26130292 .","DOI":"10.1007\/s11764-015-0463-x"},{"key":"786_CR30","doi-asserted-by":"crossref","unstructured":"Dumas JA, Newhouse PA. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav [Internet]. 2011 [cited 2014 Jan 30];99:254\u201361. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0091305711000682","DOI":"10.1016\/j.pbb.2011.02.022"},{"key":"786_CR31","doi-asserted-by":"crossref","unstructured":"Ellis JR, Ellis KA, Bartholomeusz CF, Harrison BJ, Wesnes KA, Erskine FF, et al. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol [Internet]. 2006 [cited 2014 Feb 20];9:175\u201389. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15877932 .","DOI":"10.1017\/S1461145705005407"},{"key":"786_CR32","doi-asserted-by":"crossref","unstructured":"Newhouse PA, Potter A, Corwin J, Lenox R. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology [Internet]. 1994 [cited 2014 Feb 20];10:93\u2013107. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8024677 .","DOI":"10.1038\/npp.1994.11"},{"key":"786_CR33","doi-asserted-by":"crossref","unstructured":"Vitiello B, Martin A, Hill J, Mack C, Molchan S, Martinez R, et al. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans. Neuropsychopharmacology [Internet]. 1997 [cited 2014 Feb 20];16:15\u201324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8981385 .","DOI":"10.1016\/S0893-133X(96)00134-0"},{"key":"786_CR34","doi-asserted-by":"crossref","unstructured":"Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) [Internet]. 2010 [cited 2014 Feb 25];210:453\u201369. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3151730&tool=pmcentrez&rendertype=abstract","DOI":"10.1007\/s00213-010-1848-1"},{"key":"786_CR35","doi-asserted-by":"crossref","unstructured":"Dawkins L, Powell JH, West R, Powell J, Pickering A. A double-blind placebo-controlled experimental study of nicotine: II--effects on response inhibition and executive functioning. Psychopharmacology (Berl) [Internet]. 2007 [cited 2014 Apr 9];190:457\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17205318 .","DOI":"10.1007\/s00213-006-0634-6"},{"key":"786_CR36","unstructured":"Engeland C, Mahoney C, Mohr E, Ilivitsky V, Knott V. Nicotine and sensory memory in Alzheimer\u2019s disease: an event-related potential study. Brain Cogn [Internet]. 2002 [cited 2014 Apr 9];49:232\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15259398 ."},{"key":"786_CR37","doi-asserted-by":"crossref","unstructured":"Howe MN, Price IR. Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr [Internet]. 2001 [cited 2014 Apr 9];13:465\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12003253 .","DOI":"10.1017\/S1041610201007888"},{"key":"786_CR38","doi-asserted-by":"crossref","unstructured":"Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, et al. Intravenous nicotine in Alzheimer\u2019s disease: a pilot study. Psychopharmacology (Berl) [Internet]. 1988 [cited 2014 Apr 9];95:171\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3137593 .","DOI":"10.1007\/BF00174504"},{"key":"786_CR39","doi-asserted-by":"crossref","unstructured":"Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, et al. Nicotine patches in Alzheimer\u2019s disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav [Internet]. 1995 [cited 2014 Apr 9];51:509\u201314. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7667377 .","DOI":"10.1016\/0091-3057(95)00043-V"},{"key":"786_CR40","doi-asserted-by":"crossref","unstructured":"Newhouse P, Kellar K, Aisen P, White H, Wesnes K, Coderre E, et al. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology [Internet]. 2012 [cited 2014 Feb 5];78:91\u2013101. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3466669&tool=pmcentrez&rendertype=abstract","DOI":"10.1212\/WNL.0b013e31823efcbb"},{"key":"786_CR41","doi-asserted-by":"crossref","unstructured":"Potter AS, Bucci DJ, Newhouse PA. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology (Berl) [Internet]. 2012 [cited 2014 25];220:331\u201340. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3288699&tool=pmcentrez&rendertype=abstract","DOI":"10.1007\/s00213-011-2476-0"},{"key":"786_CR42","doi-asserted-by":"crossref","unstructured":"Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol [Internet]. 2013 [cited 2014 Mar 17];40:709\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24331192 .","DOI":"10.1053\/j.seminoncol.2013.09.006"},{"key":"786_CR43","doi-asserted-by":"crossref","unstructured":"Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH SA. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology [Internet]. 2014 [cited 2014 Jul 23]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24789331 .","DOI":"10.1002\/pon.3545"},{"key":"786_CR44","doi-asserted-by":"crossref","unstructured":"Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry [Internet]. Elsevier; 2001 [cited 2019 31];49:258\u201367. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006322300010945?via%3Dihub","DOI":"10.1016\/S0006-3223(00)01094-5"},{"key":"786_CR45","doi-asserted-by":"crossref","unstructured":"Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology [Internet]. 2006 [cited 2014 May 6];67:834\u201342. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3488276&tool=pmcentrez&rendertype=abstract","DOI":"10.1212\/01.wnl.0000234032.77541.a2"},{"key":"786_CR46","doi-asserted-by":"crossref","unstructured":"Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology [Internet]. 2006 [cited 2016 May 9];67:834\u201342. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16966547 .","DOI":"10.1212\/01.wnl.0000234032.77541.a2"},{"key":"786_CR47","doi-asserted-by":"crossref","unstructured":"Dumas JA, Kutz AM, Naylor MR, Johnson J V, Newhouse PA. Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women. Neuroimage [Internet]. 2012 [cited 2015 Jun 17];60:1394\u2013403. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3303937&tool=pmcentrez&rendertype=abstract","DOI":"10.1016\/j.neuroimage.2012.01.043"},{"key":"786_CR48","doi-asserted-by":"crossref","unstructured":"Gilewski MJ, Zelinski EM, Schaie KW. The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age. Psychol Aging [Internet]. 1990 [cited 2014 May 6];5:482\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2278670 .","DOI":"10.1037\/0882-7974.5.4.482"},{"key":"786_CR49","unstructured":"Squire LR, Wetzel CD, Slater PC. Memory complaint after electroconvulsive therapy: assessment with a new self-rating instrument. Biol Psychiatry [Internet]. 1979 [cited 2014 May 6];14:791\u2013801. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/497304 ."},{"key":"786_CR50","unstructured":"Saykin AJ. Neurobehavioral function and activities of daily living rating scale (NBFADL-63 item version). Hanover, NH: Dartmouth Medical School."},{"key":"786_CR51","doi-asserted-by":"crossref","unstructured":"Jorm AF, Christensen H, Henderson AS, Korten AE, Mackinnon AJ, Scott R. Complaints of cognitive decline in the elderly: a comparison of reports by subjects and informants in a community survey. Psychol Med [Internet]. 1994 [cited 2014 May 6];24:365\u201374. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8084932 .","DOI":"10.1017\/S0033291700027343"},{"key":"786_CR52","doi-asserted-by":"crossref","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res [Internet]. [cited 2014 May 6];17:37\u201349. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7183759 .","DOI":"10.1016\/0022-3956(82)90033-4"},{"key":"786_CR53","doi-asserted-by":"crossref","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol [Internet]. 1982 [cited 2014 May 6];37:323\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7069156 .","DOI":"10.1093\/geronj\/37.3.323"},{"key":"786_CR54","doi-asserted-by":"crossref","unstructured":"Jacobs SR, Jacobsen PB, Booth-Jones M, Wagner LI, Anasetti C. Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with hematopoietic stem cell transplant patients. J Pain Symptom Manage [Internet]. 2007 [cited 2014 May 6];33:13\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17196903 .","DOI":"10.1016\/j.jpainsymman.2006.06.011"},{"key":"786_CR55","doi-asserted-by":"crossref","unstructured":"Lai J-S, Butt Z, Wagner L, Sweet JJ, Beaumont JL, Vardy J, et al. Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage [Internet]. NIH Public Access; 2009 [cited 2017 Dec 19];37:982\u201395. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19500722 .","DOI":"10.1016\/j.jpainsymman.2008.07.012"},{"key":"786_CR56","doi-asserted-by":"crossref","unstructured":"Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI. Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage [Internet]. 2014 [cited 2014 May 20];47:721\u201330. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0885392413003254","DOI":"10.1016\/j.jpainsymman.2013.05.010"},{"key":"786_CR57","first-page":"W32","volume":"7","author":"LI Wagner","year":"2009","unstructured":"Wagner LI, Sweet J, Butt Z, Lai J-S, Cella D. Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy-Cognitive Function instrument. J Support Oncol. 2009;7:W32\u20139.","journal-title":"J Support Oncol"},{"key":"786_CR58","unstructured":"The Conners continuous performance test. Toronto, Canada: multi-health systems; 1994."},{"key":"786_CR59","unstructured":"The continuous performance test. Toronto, Canada: multi-health systems; 1995."},{"key":"786_CR60","doi-asserted-by":"crossref","unstructured":"Kupke T, Lewis R. Relative influence of subject variables and neurological parameters on neuropsychological performance of adult seizure patients. Arch Clin Neuropsychol [Internet]. 1989 [cited 2014 May 21];4:351\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14591131 .","DOI":"10.1093\/arclin\/4.4.351"},{"key":"786_CR61","doi-asserted-by":"crossref","unstructured":"Hindmarch I. Psychological performance models as indicators of the effects of hypnotic drugs on sleep. Psychopharmacology Suppl [Internet]. 1984 [cited 2014 May 21];1:58\u201368. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6382255 .","DOI":"10.1007\/978-3-642-69659-6_4"},{"key":"786_CR62","doi-asserted-by":"crossref","unstructured":"Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology [Internet]. 1974 [cited 2014 Oct 2];24:1019\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4473151 .","DOI":"10.1212\/WNL.24.11.1019"},{"key":"786_CR63","doi-asserted-by":"crossref","unstructured":"Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol [Internet]. 2009 [cited 2014 Apr 1];24:165\u201378. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19395350 .","DOI":"10.1093\/arclin\/acp010"},{"key":"786_CR64","doi-asserted-by":"crossref","unstructured":"Darby D, Maruff P, Collie A, Mc Stephen M. Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology [Internet]. 2002 [cited 2014 May 21];59:1042\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12370459 .","DOI":"10.1212\/WNL.59.7.1042"},{"key":"786_CR65","doi-asserted-by":"crossref","unstructured":"Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol [Internet]. 2004 [cited 2014 Feb 18];22:2233\u20139. Available from: http:\/\/jco.ascopubs.org\/content\/22\/11\/2233.full","DOI":"10.1200\/JCO.2004.08.094"},{"key":"786_CR66","doi-asserted-by":"crossref","unstructured":"Bell ML, Dhillon HM, Bray VJ, Vardy JL. Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). J Patient-Reported Outcomes [Internet]. Springer; 2018 [cited 2019 23];2:48. Available from: https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-018-0071-4","DOI":"10.1186\/s41687-018-0071-4"},{"key":"786_CR67","doi-asserted-by":"crossref","unstructured":"Peci\u00f1a M, Bohnert ASB, Sikora M, Avery ET, Langenecker SA, Mickey BJ, et al. Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression. JAMA psychiatry [Internet]. NIH Public Access; 2015 [cited 2018 Feb 27];72:1087\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421634 .","DOI":"10.1001\/jamapsychiatry.2015.1335"},{"key":"786_CR68","doi-asserted-by":"crossref","unstructured":"Agid O, Siu CO, Potkin SG, Kapur S, Watsky E, Vanderburg D, et al. Meta-regression analysis of placebo response in antipsychotic trials, 1970\u20132010. Am J Psychiatry [Internet]. 2013 [cited 2018 Feb 27];170:1335\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23896810 .","DOI":"10.1176\/appi.ajp.2013.12030315"},{"key":"786_CR69","doi-asserted-by":"crossref","unstructured":"Colagiuri B, Schenk LA, Kessler MD, Dorsey SG, Colloca L. The placebo effect: from concepts to genes. Neuroscience [Internet]. NIH Public Access; 2015 [cited 2018 Feb 27];307:171\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26272535 .","DOI":"10.1016\/j.neuroscience.2015.08.017"},{"key":"786_CR70","doi-asserted-by":"crossref","unstructured":"Mestre TA, Shah P, Marras C, Tomlinson G, Lang AE. Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses. Neurology [Internet]. American Academy of Neurology; 2014 [cited 2018 Feb 27];82:1402\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24658930 .","DOI":"10.1212\/WNL.0000000000000340"},{"key":"786_CR71","doi-asserted-by":"crossref","unstructured":"Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry [Internet]. NIH Public Access; 2013 [cited 2018 Mar 2];170:723\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23318413 .","DOI":"10.1176\/appi.ajp.2012.12040474"},{"key":"786_CR72","doi-asserted-by":"crossref","unstructured":"Posternak MA, Zimmerman M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials. Br J Psychiatry [Internet]. 2007 [cited 2018 Feb 28];190:287\u201392. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17401033 .","DOI":"10.1192\/bjp.bp.106.028555"},{"key":"786_CR73","doi-asserted-by":"crossref","unstructured":"Oken BS. Placebo effects: clinical aspects and neurobiology. Brain [Internet]. Oxford University Press; 2008 [cited 2018 Feb 28];131:2812\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18567924 .","DOI":"10.1093\/brain\/awn116"},{"key":"786_CR74","doi-asserted-by":"crossref","unstructured":"Khan A, Kolts RL, Thase ME, Krishnan KRR, Brown W. Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. Am J Psychiatry [Internet]. 2004 [cited 2018 Mar 2];161:2045\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15514405 .","DOI":"10.1176\/appi.ajp.161.11.2045"},{"key":"786_CR75","doi-asserted-by":"crossref","unstructured":"Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol [Internet]. 2008 [cited 2018 Mar 2];48:33\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17666008 .","DOI":"10.1146\/annurev.pharmtox.48.113006.094711"},{"key":"786_CR76","unstructured":"Brody H. The placebo response. Recent research and implications for family medicine. J Fam Pract [Internet]. 2000 [cited 2018 Feb 28];49:649\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10923577 ."},{"key":"786_CR77","doi-asserted-by":"crossref","unstructured":"Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet (London, England) [Internet]. 2001 [cited 2018 Feb 28];357:757\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11253970 .","DOI":"10.1016\/S0140-6736(00)04169-6"},{"key":"786_CR78","doi-asserted-by":"crossref","unstructured":"Armey MF, Schatten HT, Haradhvala N, Miller IW. Ecological momentary assessment (EMA) of depression-related phenomena. Curr Opin Psychol [Internet]. Elsevier; 2015 [cited 2018 Apr 24];4:21\u20135. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352250X15000494","DOI":"10.1016\/j.copsyc.2015.01.002"},{"key":"786_CR79","doi-asserted-by":"crossref","unstructured":"Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol [Internet]. 2008 [cited 2018 Apr 20];4:1\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18509902 .","DOI":"10.1146\/annurev.clinpsy.3.022806.091415"},{"key":"786_CR80","doi-asserted-by":"crossref","unstructured":"Kesler SR, Blayney DW. Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol [Internet]. 2016 [cited 2016 Jul 20];2:185\u201392. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26633037 .","DOI":"10.1001\/jamaoncol.2015.4333"},{"key":"786_CR81","doi-asserted-by":"crossref","unstructured":"Cerulla N, Arcusa \u00c0, Navarro J-B, Garolera M, Enero C, Chico G, et al. Role of taxanes in chemotherapy-related cognitive impairment: a prospective longitudinal study. Breast Cancer Res Treat [Internet]. 2017 [cited 2018 Jun 5];164:179\u201387. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28421379 .","DOI":"10.1007\/s10549-017-4240-6"},{"key":"786_CR82","doi-asserted-by":"crossref","unstructured":"Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology [Internet]. 2013 [cited 2016 Oct 14];22:1517\u201327. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22936651 .","DOI":"10.1002\/pon.3163"},{"key":"786_CR83","unstructured":"American Cancer Society. Cancer facts & figures. Atlanta; 2013."},{"key":"786_CR84","doi-asserted-by":"crossref","unstructured":"Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry [Internet]. Informa Healthcare USA; 2014 [cited 2014 6];26:102\u201313. Available from: http:\/\/informahealthcare.com\/doi\/abs\/10.3109\/09540261.2013.864260","DOI":"10.3109\/09540261.2013.864260"},{"key":"786_CR85","doi-asserted-by":"crossref","unstructured":"Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. J Pain Symptom Manage [Internet]. 2015 [cited 2016 Dec 3];50:830\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26344551 .","DOI":"10.1016\/j.jpainsymman.2015.06.019"},{"key":"786_CR86","doi-asserted-by":"crossref","unstructured":"Ferguson RJ, McDonald BC, Rocque MA, Furstenberg CT, Horrigan S, Ahles TA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology [Internet]. 2012 [cited 2016 5];21:176\u201386. Available from: http:\/\/doi.wiley.com\/10.1002\/pon.1878","DOI":"10.1002\/pon.1878"},{"key":"786_CR87","doi-asserted-by":"crossref","unstructured":"Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, et al. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology [Internet]. 2007 [cited 2016 Dec 5];16:772\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17152119 .","DOI":"10.1002\/pon.1133"},{"key":"786_CR88","doi-asserted-by":"crossref","unstructured":"Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer [Internet]. 2013 [cited 2016 Dec 5];13:299\u2013306. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820913000499","DOI":"10.1016\/j.clbc.2013.02.004"},{"key":"786_CR89","doi-asserted-by":"crossref","unstructured":"Janelsins MC, Peppone LJ, Heckler CE, Kesler SR, Sprod LK, Atkins J, et al. YOCAS\u00a9\u00ae yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep. Integr Cancer Ther [Internet]. 2015 [cited 2016 Jun 1]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26621521 .","DOI":"10.1177\/1534735415617021"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-019-00786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-019-00786-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-019-00786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:58:24Z","timestamp":1664017104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-019-00786-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1007\/s11764-019-00786-6","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JN Vega, KM Albert, PA Newhouse, WD Taylor, and Paul A. Newhouse declare no conflicts of interest. IA Mayer has received consultancy\/advisory fees from AstraZeneca, Novartis, Genentech, Eli Lilly, Immunomedics, MacroGenics, and GlaxoSmithKline and received research funding from Novartis, Genentech, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki. This study was approved by the Vanderbilt-Ingram Cancer Center (VICC BRE 1692) and the Vanderbilt University Institutional Review Boards (IRB 141584).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants gave written informed consent in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}